iC42 Clinical Research & Development is a University of Colorado Service Center. It iC42 Clinical Research & Development goal to carry out own pre-clinical and clinical drug development programs, to assist basic science departments to bring drug candidates into clinical development and to serve as a resource for biotech and pharmaceutical industry. One of the major foci is the evaluation of pharmacokinetics, drug metabolism and the development of clinical management tools for pediatric patients. iC42 Clinical Research & Development is a unique facility since it combines quantitative mass spectrometry (drugs, drug metabolites, other small molecules and large molecules, endogenous compounds), metabolic and protein profiling technologies and PK/PD modeling services under one roof. iC42 Clinical Research & Development is designed and uniquely qualified to carry out the bioanalytics for complex clinical trials involving drug quantification and molecular marker strategies. iC42 Clinical Reseach & Development is accredited by the College of American Pathologists (CAP, LAP number 2182803, AU-ID 118674), is CLIA certified (06D0985306) and is an approved Site of Practice (University Physicians Inc.). In addtion, iC42 Clinical Research & Development has successfully conducted analyses for a multitude of FDA (21 CFR part 58) and OECD cGLP compliant studies.